Aspira Women's Health Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results All four companies posted net losses for the quarter, while Biodesix's results were hit by a sharp decline in COVID-19 testing revenue. Aspira Q4 Revenues up 36 Percent The company reported total revenues of $1.9 million, up from $1.4 million in Q4 2020, while sales of its OVA1plus test were up 23 percent. Aspira Women's Health Preliminary Q4 OVA1 Sales up 23 Percent; Firm Details Pipeline Progess The company also announced a five-year deal with healthcare group Axia Women's Health to provide in-house genetic carrier screening. Breaking News Hong Kong Dx Firm Prenetics Shares Down 9 Percent on First Day on Nasdaq Polygenic Risk Score Performance Improved With Expression-Related Rare Variant Insights Study Explores Familial Hypercholesterolemia Genetic Risk, Targeted Screening Possibilities BC Platforms, Euformatics, Oncompass to Develop Oncology NGS Workflows for European Hospitals Avalon GloboCare, Lu Daopei Hematology Institute Partner to Develop Cell Therapy CDx Illumina, Allegheny Health Network Collaborate on Study of Cancer Genomic Profiling The Scan Denisovan Girl's Tooth Found in Laos CNN reports that a tooth found in a cave north of Vientiane likely belonged to a Denisovan girl. A Lack of Diversity in Trials A new report from the National Academies of Science, Engineering, and Medicine examines the limited representation of diverse groups among clinical trial participants. Another Look A new inquiry is to be held after genetic evidence indicates that Kathleen Folbigg's children may have been at increased risk of sudden death, the Sydney Morning Herald reports. Nucleic Acids Research Studies on ICARUS, Neighbor-seq, CADDIE In Nucleic Acids Research this week: resource to analyze and visualize single-cell RNA-seq data, method to examine cellular interactions, and more.